B O O K - American College of Rheumatology

Upon completion of this session, participants should be able to:
• describe the advantages and limitations of animal models of
Sjögren’s syndrome and their relevance to human disease
• identify the role of B cells, B cell directed cytokines and
inflammatory mediators in the pathogenesis of Sjögren’s
syndrome and their potential as biomarkers of disease activity
and/or prognosis
• develop a better understanding of the relationship between
autonomic dysfunction and Sjögren’s syndrome and its clinical
implications
A410
Skin Diseases
Moderator: Jan P. Dutz, MD; University of Bristish Columbia;
Vancouver, BC, Canada
6:45 PM
Cutaneous Side Effects of Anti-TNF Therapy
David Wetter, MD; Mayo Clinic; Rochester, MN
7:00 PM
Multicentric Reticulocytosi a Dermatomyositis Mimic?
Nicole Fett, MD; Perelman Center for Advanced Medicine;
Philadelphia, PA
7:15 PM
Diagnosing and Treating Morphea
Heidi Jacobe, MD; UT Southwestern Medical Center at Dallas;
Dallas, TX
7:30 PM
Dematomyositis and Malignancy
Jeffrey P. Callen, MD; University Louisville School Medicine;
Louisville, KY
7:40 PM
Treatment of Raynaud’s in Patients with Low-Normal Blood
Pressure
Andrew G. Franks, MD; New York University; New York, NY
tuesday
7:50 PM
Acquired Cutis Laxa
Christan Vera Kellet, MD; Pontificia Universidad Catolica de
Chile; Santigo, Chile
Session Overview:
Skin manifestations of rheumatic disease are common. This
session will present six clinical cases involving the cutaneous
manifestations of rheumatic diseases and their treatment.
The range of diseases covered will include vascular disorders,
dermatomyositis, sclerotic conditions, and skin drug reactions.
Clinical features, importance of histopathology and treatment
approaches will be covered and presented for discussion
amongst attendees.
Upon completion of this session, participants should be able to:
• identify common and unusual cutaneous manifestations of
rheumatic disease
• describe the possible role of the dermatologist in comanagement
of these conditions
• identify the value and limitations of skin biopsy
2010 Program Book 93